Sphera Funds Management Ltd. Incyte Corp Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$52.16 - $64.19 $4.67 Million - $5.75 Million
89,556 New
89,556 $5.62 Million
Q1 2018

May 10, 2018
SELL
$83.06 - $100.98 $4.15 Million - $5.05 Million
-50,000 Closed
0 $0
Q4 2017

Feb 12, 2018
BUY
$93.56 - $116.6 $4.68 Million - $5.83 Million
50,000
50,000 $4.74 Million

Others Institutions Holding INCY

# of Institutions
643
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email